{"id":"NCT00919893","sponsor":"University of Giessen","briefTitle":"Efficacy Study of a Standardized Pollen Extract Preparation (Cernilton) to Treat Inflammatory Chronic Prostatitis-Chronic Pelvic Pain Syndrome (CP-CPPS)","officialTitle":"Phase 3 Study of a Standardized Pollen Extract Preparation (Cernilton) in Patients With Inflammatory Chronic Prostatitis-chronic Pelvic Pain Syndrome","status":"COMPLETED","phase":"PHASE3","dates":{"start":"1999-12","primaryCompletion":"2004-01","completion":"2004-01","firstPosted":"2009-06-12","resultsPosted":"2009-06-12","lastUpdate":"2020-11-20"},"enrollment":139,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Prostatitis","Chronic Pelvic Pain Syndrome"],"interventions":[{"type":"DRUG","name":"Cernilton","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Cernilton","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"In this placebo controlled study the safety and efficacy of Cernilton, a standardized pollen extract, in men with inflammatory chronic prostatitis-chronic pelvic pain syndrome was investigated. The purpose of this study is to determine whether Cernilton is safe and effective in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome.","primaryOutcome":{"measure":"Symptomatic Improvement in the Pain Domain of National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI)","timeFrame":"0, 6, 12 weeks","effectByArm":[{"arm":"Cernilton","deltaMin":47,"sd":null},{"arm":"Placebo","deltaMin":33,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.05"}]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":9},"locations":{"siteCount":1,"countries":["Germany"]},"refs":{"pmids":["8499988"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":null,"commonTop":[]}}